By Jasmin Boyce ( December 6, 2022, 5:39 PM EST) -- The U.S. government has urged a Delaware federal judge not to let drugmaker Gilead Sciences Inc. escape its patent suit over brand-name HIV treatments Truvada and Descovy, arguing that clear authority gives it standing to assert its government-owned patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.